Conservative Oxygen Therapy in Mechanically Ventilated Critically Ill Adult Patients
JAMA · 05.08.2025 · 334 (5) · 398
DOI: 10.1001/jama.2025.9663 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA, erschienen am 05.08.2025. Verfasst von Daniel S Martin und 24 weiteren Autor:innen. Beteiligte Einrichtung: Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom. Hauptthemen laut MEDLINE: Critical Illness, Oxygen Inhalation Therapy, Respiration, Artificial. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Supplemental oxygen is frequently given to patients in intensive care units (ICUs); however, there is insufficient evidence to guide its therapeutic use and to minimize the potential harm caused by administering too little or too much.
Objective
To determine whether reducing exposure to supplemental oxygen through a strategy of conservative oxygen therapy by using a peripheral oxygen saturation (Sp o 2 ) target of 90% (range, 88%-92%) reduces mortality at 90 days in mechanically ventilated adult patients receiving supplemental oxygen in the ICU. Design, Setting, and Participants Multicenter, pragmatic, randomized clinical trial conducted in 97 ICUs in the UK including 16 500 mechanically ventilated patients receiving supplemental oxygen. Participants were enrolled between May 2021 and November 2024. Follow-up was completed in February 2025.
Interventions
Participants randomized to conservative oxygen therapy (n = 8258) received the lowest fraction of inspired oxygen possible to maintain their Sp o 2 at 90%. Participants randomized to usual oxygen therapy (n = 8242) received oxygen therapy at the discretion of the treating clinician. Main Outcomes and Measures The primary outcome was all-cause mortality at 90 days. Secondary outcomes included duration of ICU and acute hospital stay among survivors, days alive and free from organ support at 30 days, and mortality at other time points.
Results
Of 16 500 randomized patients, primary outcome data were available for 16 394 (8211 in the conservative and 8183 in the usual oxygen therapy group). Randomized groups were similar (median age, 60 [IQR, 48-71] years and 38.2% females in both groups [n = 5652]). Exposure to supplemental oxygen was 29% lower for participants in the conservative oxygen therapy group compared with the usual oxygen therapy group. By 90 days, 2908 participants (35.4%) in the conservative oxygen therapy group had died compared with 2858 (34.9%) in the usual oxygen therapy group. After adjustment for prespecified baseline variables, the risk difference was 0.7 percentage points (95% CI, −0.7 to 2.0; P = .28). There were no significant differences in durations in ICU or hospital stay, days alive and free from organ support at 30 days, or mortality at other time points. Conclusions and Relevance In adult patients receiving mechanical ventilation and supplemental oxygen in the ICU, minimizing oxygen exposure through conservative oxygen therapy did not significantly reduce all-cause mortality at 90 days. Trial Registration isrctn.org Identifier: ISRCTN13384956
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom.
- Intensive Care Unit, University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.
- Clinical Trials Unit, Intensive Care National Audit & Research Centre (ICNARC), Napier House, London, United Kingdom.
- Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, United Kingdom.
- Critical Care, Maidstone and Tunbridge Wells NHS Foundation Trust, Kent, United Kingdom.
- Patient and Public Representative, Bristol, United Kingdom.
Zitieren
APA
Martin, D. S., Gould, D. W., Shahid, T., Doidge, J. C., Cowden, A., Sadique, Z., Camsooksai, J., Charles, W. N., Davey, M., Francis-Johnson, A., Garrett, R. M., Grocott, M. P. W., Jones, J., Lampro, L., Mackle, D. M., O'Driscoll, B. R., Richards-Belle, A., Rostron, A. J., Szakmány, T., …, & UK-ROX Investigators (2025). Conservative Oxygen Therapy in Mechanically Ventilated Critically Ill Adult Patients. JAMA, 334(5), 398. https://doi.org/10.1001/jama.2025.9663
Vancouver
Martin DS, Gould DW, Shahid T, Doidge JC, Cowden A, Sadique Z, et al. Conservative Oxygen Therapy in Mechanically Ventilated Critically Ill Adult Patients. JAMA. 2025;334(5):398. doi:10.1001/jama.2025.9663
BibTeX
@article{Martin2025,
author = {Martin, Daniel S and Gould, Doug W and Shahid, Tasnin and Doidge, James C and Cowden, Alex and Sadique, Zia and Camsooksai, Julie and Charles, Walton N and Davey, Miriam and Francis-Johnson, Amelia and Garrett, Roger M and Grocott, Michael P W and Jones, Joanne and Lampro, Lamprini and Mackle, Diane M and O'Driscoll, B Ronan and Richards-Belle, Alvin and Rostron, Anthony J and Szakmány, Tamás and Warren, Alex and Young, Paul J and Rowan, Kathryn M and Harrison, David A and Mouncey, Paul R and UK-ROX Investigators, UK-ROX Investigators},
title = {Conservative Oxygen Therapy in Mechanically Ventilated Critically Ill Adult Patients},
journal = {JAMA},
year = {2025},
volume = {334},
number = {5},
pages = {398},
doi = {10.1001/jama.2025.9663}
}
EUVIMED